This study illustrated that IDO1 vaccination effectively induced anti-tumor immune responses in an in vivo model of cancer where the IDO1 expression was exclusively limited to tumor-infiltrating immune cells and not tumor cells [27]. The gene discussed is IDO1; the disease is neoplasm.